• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>MedImmune

MedImmune

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Asahi Kasei Pharma Selects Evotec as Its Partner for Ion Channel Drug Discovery

    Asahi Kasei Pharma Selects Evotec as Its Partner for Ion Channel Drug Discovery

  2. Virginia Bio Announces THRiVE 2015 Bioscience Conference Featuring Governor Terry McAuliffe

    Virginia Bio Announces THRiVE 2015 Bioscience Conference Featuring Governor Terry McAuliffe

  3. Kolltan Pharmaceuticals to Present at the 2015 American Association for Cancer Research (AACR) Annual Meeting

    Kolltan Pharmaceuticals to Present at the 2015 American Association for Cancer Research (AACR) Annual Meeting

  4. Immune Pharmaceuticals to Develop Novel Topical Nanoparticle Formulation of AmiKet

    Immune Pharmaceuticals to Develop Novel Topical Nanoparticle Formulation of AmiKet

  5. Morningstar Indexes: Weekly Market Report

    Week ending April 27: Quarterly earnings continue to boost market's spirits. 

  6. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

  7. Biotech Investing for the Long Haul

    Three ways to separate long-term winners from stocks that fizzle.

  8. Services Super Sector: Major Themes

    Health-care Sector Although the median health-care stock is slightly overvalued in our opinion, we're very excited by the prospects of the health-care sector. Demographics--especially older, wealthier populations--give many of the firms we cover a strong outlook in 2007 and beyond. We're excited ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.